Breast Cancer clinical trials in Alaska

4 actively recruiting breast cancer trials at 2 sites across Alaska.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Network

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medicat…

Sponsor: SWOG Cancer Research Network

NCT ID: NCT05929768

Sites in Alaska:

Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Anchorage Radiation Therapy Center — Anchorage, Alaska
Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Alaska Oncology and Hematology LLC — Anchorage, Alaska
Alaska Women's Cancer Care — Anchorage, Alaska

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBC…

Sponsor: Novartis Pharmaceuticals

NCT ID: NCT05827081

Sites in Alaska:

Alaska Oncology and Hematology LLC — Anchorage, Alaska

View on ClinicalTrials.gov →

Phase 2 Recruiting NIH

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally adva…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT05564377

Sites in Alaska:

Alaska Women's Cancer Care — Anchorage, Alaska

View on ClinicalTrials.gov →

NA Recruiting Network

Mobile Health for Adherence in Breast Cancer Patients

This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to e…

Sponsor: ECOG-ACRIN Cancer Research Group

NCT ID: NCT06112613

Sites in Alaska:

Fairbanks Memorial Hospital — Fairbanks, Alaska

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20